HK1199218A1 - (1r,4r)-6-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9- dihydro-3h-spiro-[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome (1r,4r)-6--(n-- n,n- -)-4--4,9--3h--[-1,1-[3,4,b] ]-4- - Google Patents

(1r,4r)-6-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9- dihydro-3h-spiro-[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome (1r,4r)-6--(n-- n,n- -)-4--4,9--3h--[-1,1-[3,4,b] ]-4-

Info

Publication number
HK1199218A1
HK1199218A1 HK14112866.0A HK14112866A HK1199218A1 HK 1199218 A1 HK1199218 A1 HK 1199218A1 HK 14112866 A HK14112866 A HK 14112866A HK 1199218 A1 HK1199218 A1 HK 1199218A1
Authority
HK
Hong Kong
Prior art keywords
pyrano
indol
spiro
dihydro
cyclohexane
Prior art date
Application number
HK14112866.0A
Other languages
English (en)
Chinese (zh)
Inventor
Stefanie Frosch
Klaus Linz
Petra Bloms-Funke
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1199218A1 publication Critical patent/HK1199218A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
HK14112866.0A 2012-02-03 2014-12-23 (1r,4r)-6-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9- dihydro-3h-spiro-[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome (1r,4r)-6--(n-- n,n- -)-4--4,9--3h--[-1,1-[3,4,b] ]-4- HK1199218A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12000743 2012-02-03
PCT/EP2013/051979 WO2013113857A1 (en) 2012-02-03 2013-02-01 (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
HK1199218A1 true HK1199218A1 (en) 2015-06-26

Family

ID=47628188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112866.0A HK1199218A1 (en) 2012-02-03 2014-12-23 (1r,4r)-6-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9- dihydro-3h-spiro-[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome (1r,4r)-6--(n-- n,n- -)-4--4,9--3h--[-1,1-[3,4,b] ]-4-

Country Status (24)

Country Link
US (1) US20130202701A1 (xx)
EP (1) EP2809320B1 (xx)
JP (1) JP6126134B2 (xx)
KR (1) KR102061482B1 (xx)
CN (1) CN104168897B (xx)
AU (1) AU2013214223B2 (xx)
BR (1) BR112014019136A8 (xx)
CA (1) CA2863572C (xx)
CY (1) CY1118799T1 (xx)
DK (1) DK2809320T3 (xx)
EA (1) EA025500B1 (xx)
ES (1) ES2629211T3 (xx)
HK (1) HK1199218A1 (xx)
HR (1) HRP20170581T1 (xx)
IL (1) IL233871B (xx)
LT (1) LT2809320T (xx)
MX (1) MX353740B (xx)
NZ (1) NZ629800A (xx)
PL (1) PL2809320T3 (xx)
PT (1) PT2809320T (xx)
RS (1) RS56097B1 (xx)
SI (1) SI2809320T1 (xx)
WO (1) WO2013113857A1 (xx)
ZA (1) ZA201406447B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3247352T3 (da) 2015-01-23 2020-09-07 Gruenenthal Gmbh Cebranopadol til behandling af smerter hos individer med forringet lever- og/eller forringet nyrefunktion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2005092858A2 (en) * 2004-03-29 2005-10-06 Pfizer Japan Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
KR20090015089A (ko) * 2006-05-31 2009-02-11 세프라코 아이엔시. 트랜스 4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로-1-나프탈렌아민 및 그의 포름아미드에 의한 통증장애 치료방법
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

Also Published As

Publication number Publication date
BR112014019136A2 (xx) 2017-06-20
CN104168897A (zh) 2014-11-26
EP2809320A1 (en) 2014-12-10
US20130202701A1 (en) 2013-08-08
LT2809320T (lt) 2017-05-25
DK2809320T3 (en) 2017-05-15
CA2863572C (en) 2019-08-27
EA025500B1 (ru) 2016-12-30
NZ629800A (en) 2016-06-24
SI2809320T1 (sl) 2017-07-31
AU2013214223B2 (en) 2017-03-23
MX353740B (es) 2018-01-26
AU2013214223A1 (en) 2014-09-18
IL233871B (en) 2018-06-28
IL233871A0 (en) 2014-09-30
CN104168897B (zh) 2016-09-28
MX2014008865A (es) 2014-08-27
ES2629211T3 (es) 2017-08-07
KR20140130695A (ko) 2014-11-11
JP6126134B2 (ja) 2017-05-10
RS56097B1 (sr) 2017-10-31
WO2013113857A1 (en) 2013-08-08
HRP20170581T1 (hr) 2017-06-16
PL2809320T3 (pl) 2017-09-29
CY1118799T1 (el) 2018-01-10
JP2015505553A (ja) 2015-02-23
ZA201406447B (en) 2016-02-24
EA201400857A1 (ru) 2015-01-30
BR112014019136A8 (pt) 2017-07-11
KR102061482B1 (ko) 2020-01-03
CA2863572A1 (en) 2013-08-08
PT2809320T (pt) 2017-06-30
EP2809320B1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
HK1213877A1 (zh) 用於激酶調節的化合物和方法及其適應症
EP2728157A4 (en) ADSORPTIONANTS FOR CANISTERS AND CANISTERS
EP2876105A4 (en) 1- (CYCLOALKYL-CARBONYL) PROLINE DERIVATIVE
ZA201504401B (en) Filter arrangements; components; assemblies; and, methods
SG11201503035XA (en) Gas separation method using ddr type zeolites with stabilized adsorption activity
EP2737829A4 (en) BED COMBINATION METHOD, BED SEPARATION METHOD, AND BED THEREOF
SG10201607813SA (en) Compounds and methods for kinase modulation, and indications therefor
PL2931417T3 (pl) Adsorbenty zeolitowe i ich zastosowanie
ZA201305856B (en) Compounds and methods for kinase modulation,and indications therefor
ZA201308395B (en) Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/orbace2 inhibitors
MX312376B (es) Metodos de estabilización e hidrogenacion de olefinas de origen microbiano.
GB201306151D0 (en) Media content distribution
EP2800717A4 (en) ELEVATOR ARRANGEMENT AND METHOD FOR REPLACING THE ELEVATOR ARRANGEMENT
SG11201404609XA (en) Agent for improving aroma intensity and/or aroma quality
EP2878449A4 (en) MEDIUM RETENTION DEVICE, MEDIUM TRANSPORT DEVICE, AND INK JET PRINTING DEVICE
EP2836528A4 (en) METHODS OF MAKING LAMINATED, SATURATED AND ABRASIVE PRODUCTS
HK1204943A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and a gabapentinoid (1r4r)-6--nn--4--49--3h-[-1 1-[34b]]-4-
HK1199218A1 (en) (1r,4r)-6-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9- dihydro-3h-spiro-[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome (1r,4r)-6--(n-- n,n- -)-4--4,9--3h--[-1,1-[3,4,b] ]-4-
HK1199258A1 (zh) '- '- '- '-氟代- -二甲基- -苯基- '， '-二氫- -螺環- 環己烷- '-吡喃並 吲哚基 -鹽酸胺的固體形式
HK1204938A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and a nsar (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4- nsar
IL235380B (en) Method for checking the alignment of print heads and associated alignment method
EP2813055A4 (en) METHOD, DEVICE AND COMPUTER READABLE MEDIUM FOR ACCESS AUTHORIZATION
HK1204944A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and antidepressants (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
HK1204939A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1-pyrano [3,4,b]indol]-4-amine and an oxicam (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
HUP1200271A2 (en) Wine spritzer with juice

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210204